Arcturus Therapeutics Holdings Inc.
PublicArcturus Therapeutics Holdings Inc. is now publicly traded
The data on this page reflects Arcturus Therapeutics Holdings Inc.'s private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Last Round
Seed
Jun 30, 2026
Total Funding Raised
$8M
Company Overview
Arcturus Therapeutics Holdings Inc. is a biotechnology company that develops mRNA medicines and vaccines for infectious diseases and rare liver and respiratory conditions.
Sector
Healthcare
AI Layer
Non-AI
Keywords
Arcturus Therapeutics Holdings Inc. Comparables
Compare Arcturus Therapeutics Holdings Inc. with similar companies based on industry and business-model similarity.
No public comparables are available for Arcturus Therapeutics Holdings Inc.. Request access to learn about comparables coverage.
Request accessArcturus Therapeutics Holdings Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jun 30, 2026 |
Key People
Founding team and executive leadership
Arcturus Therapeutics Holdings Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| 1517 Fund | Seed |
| Wireframe Ventures | Seed |
| Climate Capital | Seed |
| Initialized Capital Management | Seed |
| Breakthrough Energy Discovery | Seed |
| Toyota Ventures | Seed |
| Wireframe Ventures | Seed |
Arcturus Therapeutics Holdings Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access